ABSTRACT
4

Introduction
48
Local anesthetics are clinically used for the treatment of tendinopathies. Peritendinous 49 injections of local anesthetics, in combination with other drugs (e.g., steroids), are given around 50 various joints to treat lateral and medial epicondylitis of the elbow, de Quervain's disease, 51 patellar and pes anserine tendinopathies, and Achilles tendinopathy [1] [2] [3] [4] [5] [6] . Similarly, subacromial 52 injections of anesthetic agents are used in rotator cuff tears as therapeutic and diagnostic tools 53 [7] . 54 However, in vitro studies have shown the toxicity of local anesthetics on tendon 55 fibroblasts [8] [9] [10] [11] . Lehner et al. reported that the treatment of rat tendon-derived cells with 0.5% 56 bupivacaine for 10 min had detrimental effects on cell viability [8] . Piper et al. showed a toxic 57 effect of 30 min of 1% lidocaine treatment on bovine tendon fibroblasts [9] . Yang et al. Despite the deleterious effects of the local anesthetics as evaluated by in vitro studies 11], lidocaine is frequently used preoperatively in clinical practice in rotator cuff tears [12] [13] [14] [15] ; 65 
5
however, in vivo data on the effects of lidocaine are lacking. These results prompted us to 66 examine how lidocaine acts on rotator cuff tears when used in subacromial injection for this 67 disease. Thus, the purpose of the present study was to evaluate the effects of lidocaine on 68 cultured tenocytes from human rotator cuff tendons in an animal cuff tear model. We 69 hypothesized that lidocaine has deleterious effects on tenocytes in vitro and in vivo. 
Methods
72
Lidocaine was purchased from Maruishi (1% lidocaine injection; Osaka, Japan).
73
Dulbecco's modified Eagle's medium (DMEM) and L-glutamine were purchased from Nissui 74 Seiyaku (Tokyo, Japan), and fetal bovine serum (FBS) was purchased from Thermo Scientific
75
(Tokyo, Japan).
77
Study Design
78
All applicable international, national, and our institutional guidelines for the care and 79 use of animals and Ethics Committee were followed. Informed consent was obtained from all 80 individual participants included in the study. All tests and measurements were performed blindly. tendons were cultured in monolayers at various concentrations of lidocaine (0.001%, 0.01%, 84 0.05%, and 0.1%); 9 specimens were used in the cell-proliferation assay, and 5 specimens were 85 used in the cell-viability assay. A singlicate analysis was performed to collect experiment data.
86
For the cell-proliferation assay, cultured cells from a specimen were divided into 5 87 groups and exposed to 5 graded concentrations of lidocaine (control, 0.001%, 0.01%, 0.05%, and 88 0.1%). Therefore, 9 data points were obtained in total. For the cell-viability assay, cultured cells 89 from a specimen were divided into 2 groups and exposed to either 0% or 1% lidocaine.
90
Therefore, 5 data points were obtained in total.
91
For the in vivo experiments, adult Sprague-Dawley rats (n = 33) underwent bilateral 92 shoulder surgery, and a total of 66 shoulders were assessed. The shoulders were allocated into 2 93 groups: lidocaine and control. Each group consisted of 6 specimens for biomechanical testing 94 and 3 for histological analysis and was evaluated 2, 4, and 8 weeks after surgery. Six specimens 95 in each group were subjected to 3 TUNEL staining and 3 electron microscopy analyses 24 h after 96 surgery ( Figure 1 ).
98
Tissue preparation
99
Fourteen patients (9 males, 5 females) with rotator cuff disease were included in this 100 study. Nine subjects had right shoulder involvement, and 5 subjects had left shoulder 101 7 involvement. There were 2 small, 5 middle, 3 large, and 4 massive tears. Average subject age 102 was 62.4 ± 9.6 years, and the average period from symptom onset was 69.7 ± 73.8 weeks. All the 103 patients had received subacromial injections of a steroid or hyaluronic acid in addition to 104 physical therapy. Arthroscopic cuff repair was performed for a minimum of 2 months after the 105 last subacromial injection to minimize any potential effects of the agents.
106
The specimensSpecimens of the rotator cuff tendon were 3-5 mm in width and were 107 obtained from the margins of human rotator cuff tendons. The biopsy was performed in the 108 supraspinatus tendon and partly in the infraspinatus tendon when the tear size was large or 109 massive. Care was taken not to contaminate other types of adjacent tissue (muscle or synovium).
110
The cuff tear was completely repaired without excessive tension at the sides. curve. This testing protocol was similar to that described previously [16, 17] . collagen. This testing protocol was similar to that described previously [19, 20] .
184
To evaluate apoptosis at the torn site, tendon specimens were subjected to TUNEL 185 staining 24 h after surgery using an in situ cell death kit (WAKO Chemical, Japan) according to 
Results
219
Cell Proliferation
220
When the values in the control group were defined as 100%, the relative ratio between the 2 groups were noted at 2 and 4 weeks after surgery.
237
The stiffness values (lidocaine vs. control group) were as follows: 9.9 ± 6.1 N/mm and caused adverse effects on tenocytes in torn rotator cuff tendons.
274
In vitro studies [21] [22] [23] [24] have demonstrated considerable local anesthetic toxicity on 275 various cell types, including tendon fibroblasts derived from bovine tendon [3] and torn human 276 rotator cuff tendons [5] . Recently, an in vitro study revealed the cytotoxic mechanism of 277 aminoamide local anesthetics acting on human rotator cuff tendon fibroblasts [5] . That study 278 evaluated the response of tendon fibroblasts to ropivacaine, bupivacaine, and lidocaine and found 279 that these anesthetics caused cell death that was mediated by increased production of reactive bupivacaine-treated and control groups [25] . In our rat cuff tear model, a single injection of 1.0% 291 lidocaine caused apoptotic changes in tenocytes 24 h after surgery and delayed organization at 292 the tear site by 4 weeks after surgery. These discrepancies appear to be either related to 293 differences in the animal models or the concentrations of local anesthetics used in these studies.
294
Unlike the "cuff tear" model in the present study or the "peritendinous injection" model 295 reported by Lehner et al. [2] , a "tear and subsequent repair" model [26, 27] may not have 296 predisposed tenocytes to be exposed at sufficient levels of concentration because the cells are inhibited cell proliferation and/or viability in a dose-dependent manner [4, 23, 28] . Thus, the 302 milieu of the injection site seems to directly determine the effects of local anesthetics; in fact, in 303 the present study, the tenocytes at the edge of the tear site that were directly exposed to lidocaine,
304
but not the cells exposed to PBS (control), underwent apoptotic changes.
305
We previously demonstrated the healing capability of torn tendon edges in patients with fibroblasts [29] [30] [31] [32] . These procollagen gene expression levels at the edge of the torn tendon 308 significantly correlated with re-tear after surgery [29] . In the present study, significant decrease 309 in the ultimate load to failure and delay of collagen organization in the lidocaine group continued 310 at 4 weeks after surgery. In a randomized, double-blind, prospective study, the accuracies of 311 landmark-and ultrasound-guided injections were 70% and 65%, respectively, for subacromial 312 space (P < 0.05) [33] [34] . Taking these into considerations, lidocaine administration into the 313 subacromial space may affect the tenocytes when directly injected into the tendon mid-314 substance; therefore, careful administration of lidocaine is necessary before operation. (e.g., stress, modulus), which may add significant uncertainty to the interpretation of findings.
331
Eighth, the sample size in this study was small, which may have caused a type II statistical error.
332
Resolution of these issues would add clarity to our study findings. 
